» Articles » PMID: 28290522

Nutritional Control of IL-23/Th17-mediated Autoimmune Disease Through HO-1/STAT3 Activation

Abstract

The nutritional curcumin (CUR) is beneficial in cell-mediated autoimmune diseases. The molecular mechanisms underlying this food-mediated silencing of inflammatory immune responses are poorly understood. By investigating antigen-specific immune responses we found that dietary CUR impairs the differentiation of Th1/Th17 cells in vivo during encephalomyelitis and instead promoted Th2 cells. In contrast, feeding CUR had no inhibitory effect on ovalbumin-induced airway inflammation. Mechanistically, we found that CUR induces an anti-inflammatory phenotype in dendritic cells (DC) with enhanced STAT3 phosphorylation and suppressed expression of Il12b and Il23a. On the molecular level CUR readily induced NRF2-sensitive heme oxygenase 1 (HO-1) mRNA and protein in LPS-activated DC. HO-1 enhanced STAT3 phosphorylation, which enriched to Il12b and Il23a loci and negatively regulated their transcription. These findings demonstrate the underlying mechanism through which a nutritional can interfere with the immune response. CUR silences IL-23/Th17-mediated pathology by enhancing HO-1/STAT3 interaction in DC.

Citing Articles

Recent clinical evidence on nutrition, novel pharmacotherapy, and vaccination in inflammatory bowel diseases.

Gheonea T, Bogdan M, Meca A, Rogoveanu I, Oancea C Front Pharmacol. 2024; 15:1380878.

PMID: 39308999 PMC: 11413590. DOI: 10.3389/fphar.2024.1380878.


Curcumin as a regulator of Th17 cells: Unveiling the mechanisms.

Ghoushi E, Poudineh M, Parsamanesh N, Jamialahmadi T, Sahebkar A Food Chem (Oxf). 2024; 8:100198.

PMID: 38525269 PMC: 10959653. DOI: 10.1016/j.fochms.2024.100198.


What nature has to offer: Opportunities for immuno-oncology.

Kousar R, Lin C, Patrick B, He M, Wu D, Li X J Food Drug Anal. 2023; 31(2):212-231.

PMID: 37335163 PMC: 10281724. DOI: 10.38212/2224-6614.3459.


Niosomal Curcumin Suppresses IL17/IL23 Immunopathogenic Axis in Skin Lesions of Psoriatic Patients: A Pilot Randomized Controlled Trial.

Kolahdooz H, Khori V, Erfani-Moghadam V, Livani F, Mohammadi S, Memarian A Life (Basel). 2023; 13(5).

PMID: 37240721 PMC: 10224439. DOI: 10.3390/life13051076.


The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation.

Moudgil K, Venkatesha S Int J Mol Sci. 2023; 24(1).

PMID: 36613560 PMC: 9820125. DOI: 10.3390/ijms24010095.


References
1.
Liu L, Shang Y, Li M, Han X, Wang J, Wang J . Curcumin ameliorates asthmatic airway inflammation by activating nuclear factor-E2-related factor 2/haem oxygenase (HO)-1 signalling pathway. Clin Exp Pharmacol Physiol. 2015; 42(5):520-9. DOI: 10.1111/1440-1681.12384. View

2.
Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T . Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell. 2009; 15(2):114-23. PMC: 2673504. DOI: 10.1016/j.ccr.2008.12.018. View

3.
Shen G, Xu C, Hu R, Jain M, Gopalkrishnan A, Nair S . Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin. Mol Cancer Ther. 2006; 5(1):39-51. DOI: 10.1158/1535-7163.MCT-05-0293. View

4.
Bill M, Nicholas C, Mace T, Etter J, Li C, Schwartz E . Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines. PLoS One. 2012; 7(8):e40724. PMC: 3416819. DOI: 10.1371/journal.pone.0040724. View

5.
Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S . Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med. 2005; 11(12):1314-21. DOI: 10.1038/nm1325. View